ERTUGLIFLOZIN AND SITAGLIPTIN

ERTUGLIFLOZIN AND SITAGLIPTIN was reported 120 times

ERTUGLIFLOZIN AND SITAGLIPTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PYELOCYSTITIS 1 0.0833
1 ALCOHOL TEST POSITIVE 1 0.0213
2 HYPERGLYCAEMIC CRISIS 1 0.0192
3 HAEMORRHAGIC NECROTIC PANCREATITIS 1 0.0133
4 PANCREATIC DUCT OBSTRUCTION 2 0.0112
5 WOUND NECROSIS 2 0.0042
6 DIABETIC RETINOPATHY 4 0.0012
7 COVID-19 PNEUMONIA 12 0.0010
8 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
9 CAROTID ARTERIOSCLEROSIS 1 0.0010
10 PANCREATITIS NECROTISING 2 0.0009
11 DIABETIC NEUROPATHY 4 0.0008
12 OVERWEIGHT 4 0.0007
13 DIABETIC FOOT INFECTION 1 0.0007
14 KETOACIDOSIS 5 0.0007
15 GASTROSTOMY 1 0.0006
16 BLOOD CREATININE DECREASED 2 0.0006
17 PROTEIN TOTAL DECREASED 2 0.0005
18 ORGAN FAILURE 2 0.0005
19 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2 0.0005
20 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
21 HYPERCHOLESTEROLAEMIA 4 0.0004
22 ENTEROCOCCAL INFECTION 2 0.0004
23 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
24 FLUID INTAKE REDUCED 2 0.0004
25 POLYMYALGIA RHEUMATICA 1 0.0003
26 HEPATIC CYTOLYSIS 4 0.0003
27 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
28 ONYCHOCLASIS 2 0.0003
29 NECROTISING FASCIITIS 1 0.0003
30 BRADYCARDIA 15 0.0003
31 BLOOD ALBUMIN DECREASED 2 0.0003
32 HEPATIC PAIN 1 0.0002
33 TOE AMPUTATION 1 0.0002
34 WEIGHT LOSS POOR 1 0.0002
35 BLOOD CALCIUM DECREASED 2 0.0002
36 BLOOD URIC ACID INCREASED 1 0.0002
37 GANGRENE 1 0.0002
38 VULVOVAGINAL BURNING SENSATION 1 0.0002
39 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
40 LYMPHOPENIA 2 0.0001
41 MOUTH HAEMORRHAGE 1 0.0001
42 LABORATORY TEST ABNORMAL 4 0.0001
43 ACIDOSIS 1 0.0001
44 GINGIVAL PAIN 1 0.0001
45 HAIR DISORDER 1 0.0001
46 PYELONEPHRITIS 1 0.0001
47 CARDIAC FAILURE 9 0.0001
48 UROSEPSIS 1 0.0001
49 PRODUCT PACKAGING ISSUE 1 0.0001
50 INCREASED APPETITE 2 0.0001
51 ERUCTATION 2 0.0001
52 VITAMIN D DEFICIENCY 1 0.0001
53 HEPATOMEGALY 1 0.0001
54 VITREOUS FLOATERS 1 0.0001
55 SINUS DISORDER 2 0.0001
56 BLOOD GLUCOSE FLUCTUATION 1 0.0001
57 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
58 FUNGAL INFECTION 3 0.0001
59 TRANSAMINASES INCREASED 2 0.0001
60 PRODUCT AVAILABILITY ISSUE 2 0.0001
61 MADAROSIS 1 0.0001
62 HYPERGLYCAEMIA 3 0.0001
63 MUSCLE SPASTICITY 1 0.0001
64 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
65 HAIR COLOUR CHANGES 1 0.0001
66 DYSPNOEA EXERTIONAL 3 0.0001
67 PULMONARY CONGESTION 1 0.0001
68 HAIR TEXTURE ABNORMAL 1 0.0001
69 COVID-19 13 0.0001
70 ECONOMIC PROBLEM 1 0.0001
71 LUNG INFECTION 1 0.0001
72 BRAIN FOG 1 0.0001
73 BLOOD POTASSIUM INCREASED 1 0.0001
74 CHOLELITHIASIS 2 0.0001
75 VIRAL INFECTION 2 0.0001
76 URINARY RETENTION 2 0.0001
77 CANDIDA INFECTION 1 0.0001
78 ORTHOSTATIC HYPOTENSION 1 0.0001
79 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
80 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
81 GOUT 1 0.0001
82 TOOTHACHE 1 0.0001
83 BLOOD GLUCOSE ABNORMAL 1 0.0001
84 BLOOD GLUCOSE INCREASED 10 0.0001
85 SKIN FISSURES 1 0.0001
86 FEEDING DISORDER 1 0.0000
87 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
88 LIVER DISORDER 2 0.0000
89 COLITIS ULCERATIVE 2 0.0000
90 NEPHROLITHIASIS 2 0.0000
91 DISEASE RECURRENCE 2 0.0000
92 DIABETIC KETOACIDOSIS 1 0.0000
93 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
94 OXYGEN SATURATION DECREASED 2 0.0000
95 TARDIVE DYSKINESIA 1 0.0000
96 NASAL CONGESTION 2 0.0000
97 NO ADVERSE EVENT 6 0.0000
98 VOMITING 15 0.0000
99 DRUG INTOLERANCE 3 0.0000
100 PRODUCT DOSE OMISSION 2 0.0000
101 PRODUCT DOSE OMISSION ISSUE 9 0.0000
102 DYSPEPSIA 3 0.0000
103 TYPE 2 DIABETES MELLITUS 1 0.0000
104 HYPERTENSION 6 0.0000
105 DYSPNOEA 16 0.0000
106 DYSURIA 1 0.0000
107 EPISTAXIS 2 0.0000
108 DYSARTHRIA 1 0.0000
109 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
110 CARDIAC ARREST 2 0.0000
111 URINARY TRACT INFECTION 4 0.0000
112 VAGINAL HAEMORRHAGE 1 0.0000
113 MENTAL DISORDER 1 0.0000
114 THROAT IRRITATION 1 0.0000
115 RENAL DISORDER 1 0.0000
116 BLOOD CHOLESTEROL INCREASED 1 0.0000
117 PRODUCT USE ISSUE 4 0.0000
118 COMA 1 0.0000
119 ALOPECIA 4 0.0000
120 ILLNESS 2 0.0000
121 MUSCULOSKELETAL PAIN 1 0.0000
122 PANCREATITIS 1 0.0000
123 OEDEMA 1 0.0000
124 SEPSIS 2 0.0000
125 JOINT SWELLING 2 0.0000
126 OEDEMA PERIPHERAL 2 0.0000
127 BLOOD CREATININE INCREASED 1 0.0000
128 VISION BLURRED 2 0.0000
129 SLEEP DISORDER 1 0.0000
130 INCORRECT DOSE ADMINISTERED 3 0.0000
131 ACUTE KIDNEY INJURY 2 0.0000
132 PARAESTHESIA 2 0.0000
133 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
134 MYALGIA 2 0.0000
135 RASH 5 0.0000
136 NASOPHARYNGITIS 2 0.0000
137 OROPHARYNGEAL PAIN 1 0.0000
138 HEART RATE INCREASED 1 0.0000
139 SYNCOPE 1 0.0000
140 CHEST DISCOMFORT 1 0.0000
141 ABDOMINAL DISTENSION 1 0.0000
142 WEIGHT INCREASED 2 0.0000
143 MUSCULAR WEAKNESS 1 0.0000
144 ABDOMINAL PAIN 2 0.0000
145 PSORIASIS 1 0.0000
146 WEIGHT DECREASED 2 0.0000
147 BLOOD PRESSURE INCREASED 1 0.0000
148 PERIPHERAL SWELLING 1 0.0000
149 DRUG INTERACTION 1 0.0000
150 URTICARIA 1 0.0000
151 CEREBROVASCULAR ACCIDENT 1 0.0000
152 MUSCLE SPASMS 1 0.0000
153 CHEST PAIN 1 0.0000
154 HYPERSENSITIVITY 1 0.0000
155 GAIT DISTURBANCE 1 0.0000
156 SOMNOLENCE 1 0.0000
157 MALAISE 2 0.0000
158 FEELING ABNORMAL 1 0.0000
159 INSOMNIA 1 0.0000
160 COUGH 1 0.0000
161 DRUG INEFFECTIVE 4 0.0000
162 FATIGUE 2 0.0000
163 ARTHRALGIA 1 0.0000
164 DIZZINESS 1 0.0000
165 PAIN 1 0.0000
166 HEADACHE 1 0.0000
167 DIARRHOEA 1 0.0000
168 DEATH 1 0.0000
169 OFF LABEL USE 1 0.0000